$TRNS

Transcat (NASDAQ:TRNS) reported Q2 CY2026 results. Revenue rose 21.6% year on year to $92.95 million, topping Wall Street estimates by 7.4%. Non-GAAP adjusted EPS was $0.51, up 35.1% versus analysts’ consensus and down from $0.59 a year earlier. Analysts expect revenue to grow about 6% over the next 12 months.

TRANSCAT INC (TRNS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 trns-20260804xex991.htm EX-99.1 Document Exhibit 99.1 NEWS RELEASE Transcat, Inc. 35 Vantage Point Drive • Rochester • NY • 14624 • Phone: (585) 352-7777 Transcat Reports Strong Fiscal First Quarter 2027 Financial Results with Double-Digit Service Organic Revenue* Growt

Transcat’s CEO Jaime Irick said he will apply Lean Six Sigma to improve efficiency, cycle times, customer-facing processes, and innovation. CFO Thomas Barbato noted Q4 service gross margins were pressured by new customer onboarding, expecting normalization in fiscal 2027 H1 and year-over-year margin gains for the full year. He reiterated an M&A push into new geographies, citing a Latin America SCM acquisition in Costa Rica and exploring sites in several US regions; rental is expected to grow low

Transcat (NASDAQ:TRNS) reported fiscal Q4 consolidated revenue up 16% to $89.3M and full-year revenue up 19% to $331.9M, according to management on its earnings call. Service revenue rose 18% (7% organic) and marked 68 straight quarters of YoY service growth; service gross margin was 35.5%. Adjusted Q4 EPS was $0.56; full-year adjusted EPS $1.84. Management expects higher service organic growth in fiscal Q1 vs Q4.

Transcat (NASDAQ:TRNS) reported Q4 FY2026 consolidated revenue of $89.3 million, up 16%, and full-year revenue growth of 19%. Service revenue rose 18% in Q4 and 20% for the year, supporting gross profit up 18% and gross margin expansion of 50 bps. Adjusted EBITDA grew 23% for the full year. The company said its SCM Metrology acquisition expands operations into Latin America.

Transcat Inc is anticipated to report earnings of 56 cents per share. This information is part of an earnings preview.

A recent StockStory analysis reveals Wall Street's divided opinions on three stocks, with a buy recommendation for Skyward Specialty Insurance (SKWD) and sell signals for Transcat (TRNS) and Purple (PRPL). While analysts generally project significant upside, sell ratings are rare due to potential conflicts of interest. The report outlines specific financial concerns for TRNS and PRPL, contrasting them with SKWD's strong performance indicators.

Vanguard Capital Management reported a beneficial ownership of 475,732 shares, or 5.09%, of Transcat Inc (NASDAQ: TRNS) common stock as of March 31, 2026, as disclosed in a Schedule 13G filing. Vanguard exercises sole dispositive power over all these shares and sole voting power over 68,571 shares. This significant passive stake indicates that Vanguard views Transcat as an investment rather than an attempt to influence control, with holdings managed across various Vanguard funds and accounts.

Five research firms have issued a consensus "Hold" rating for Transcat, Inc. (NASDAQ:TRNS), with an average 1-year price target of $105.3333. Despite some analysts cutting their ratings, institutional investment in Transcat has increased significantly over recent quarters. The company reported quarterly earnings below consensus but exceeded revenue expectations, with analysts predicting $2.3 EPS for the current fiscal year.

Transcat, Inc. (Nasdaq: TRNS) has acquired SCM Metrology and Laboratories S.A. for approximately $13 million in cash, marking its first operational expansion into Latin America. This acquisition enhances Transcat's ability to serve multinational customers in highly regulated markets, particularly in medical device and life sciences, by providing a broader local service footprint and creating new distribution sales opportunities in Costa Rica. SCM brings over 20 years of experience and is an ISO/IEC 17025-accredited calibration laboratory, strengthening Transcat's global service capabilities.